Vitrolife AB (publ) (VITR) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

effects arises from the net investment in foreign subsidiaries. Revelation impacts the equity. Assets and liabilities translated at the closing date rate. Revelation impacts other operating items. Transaction effects attributable to income and expenses converted at the average rate for the period. However, transactions in foreign currency are measured in functional currency at the exchange rate that applies on the transaction date. Now over to impact that has been observed in this result for the period. In Q1, if I could draw your attention to the arrow on the right hand side, we can clearly see a significant strength in Swedish crown versus other currencies by the end of the quarter one, which impacted the result with translation effect of minus 13 million SEK, but no major transaction effects in the period. In Q2, Swedish crown currency has been less volatile and we can see less impact of translation effect in the operating expenses amounted to minus 5 million SEK for the quarter, but significant transaction effects in the result. Going to the currency effects in sales Q2 2025, it's amounted to 73 million SEK, corresponding to minus 8% for the quarter. And currency effects on the sales year-to-date 2025 totaled to minus 77 million SEK, representing approximately minus 4% for the period. Notably, only minus 4 million SEK of this impact relates to the transaction effects from Q1 2025. A large part of the transaction effect was visible already in the gross result. But when it comes to operating costs, there is a counteract effect of foreign cost and their currency impact. But still, we have a large part of the operating cost in Swedish krona. As a reference, in 2024, changing the Swedish crown exchange rate against Vitrolab Group all top currencies of plus minus 10% w...